| Natasha Mozumdar Carlson, MD | |
|
3794 Hecktown Rd Ste 250, Easton, PA 18045-2355 | |
| (484) 546-5800 | |
| (484) 544-0122 |
| Full Name | Natasha Mozumdar Carlson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 6 Years |
| Location | 3794 Hecktown Rd Ste 250, Easton, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376035485 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MT215792 (Pennsylvania) | Secondary |
| 207Q00000X | Family Medicine | MD474791 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| St Luke's Warren Hospital | Phillipsburg, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Researchers have identified a potential biological mechanism that could explain why oral contraceptives may be less effective at preventing pregnancy in obese women, as some epidemiological studies have indicated.
A blue-ribbon project group funded by the National Institutes of Health has published the first consensus guidelines on how researchers should share genomic findings in research on adults and children with other family members. The recommendations, published in the Journal of Law, Medicine & Ethics, offer direction on sharing information before and after the death of an individual research participant.
Genocea Biosciences Inc., a vaccine discovery and development company pioneering a new class of T cell-based vaccines, today announced that it has closed a $35 million Series B round of venture financing, with new investors Johnson & Johnson Development Corporation (JJDC), Skyline Ventures and MP Healthcare Venture Management, Inc. (MPH) joining existing investors Polaris Venture Partners, Lux Capital Management, SR One, Cycad Group, Auriga Partners and Morningside Ventures.
University of Miami researchers have discovered a clue in the humble zebrafish's digestive tract that, one day, could help people on the autism spectrum alleviate one of the most common yet least studied symptoms of their disorder: gastrointestinal distress.
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership leading the development of new and affordable tuberculosis (TB) drugs, announced today a new grant and pledge of up to $40 million over the next five years from the United States Agency for International Development (USAID).
› Verified 8 days ago
| Entity Name | Family Care Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669563037 PECOS PAC ID: 5395649347 Enrollment ID: O20031121000497 |
News Archive
Researchers have identified a potential biological mechanism that could explain why oral contraceptives may be less effective at preventing pregnancy in obese women, as some epidemiological studies have indicated.
A blue-ribbon project group funded by the National Institutes of Health has published the first consensus guidelines on how researchers should share genomic findings in research on adults and children with other family members. The recommendations, published in the Journal of Law, Medicine & Ethics, offer direction on sharing information before and after the death of an individual research participant.
Genocea Biosciences Inc., a vaccine discovery and development company pioneering a new class of T cell-based vaccines, today announced that it has closed a $35 million Series B round of venture financing, with new investors Johnson & Johnson Development Corporation (JJDC), Skyline Ventures and MP Healthcare Venture Management, Inc. (MPH) joining existing investors Polaris Venture Partners, Lux Capital Management, SR One, Cycad Group, Auriga Partners and Morningside Ventures.
University of Miami researchers have discovered a clue in the humble zebrafish's digestive tract that, one day, could help people on the autism spectrum alleviate one of the most common yet least studied symptoms of their disorder: gastrointestinal distress.
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership leading the development of new and affordable tuberculosis (TB) drugs, announced today a new grant and pledge of up to $40 million over the next five years from the United States Agency for International Development (USAID).
› Verified 8 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Researchers have identified a potential biological mechanism that could explain why oral contraceptives may be less effective at preventing pregnancy in obese women, as some epidemiological studies have indicated.
A blue-ribbon project group funded by the National Institutes of Health has published the first consensus guidelines on how researchers should share genomic findings in research on adults and children with other family members. The recommendations, published in the Journal of Law, Medicine & Ethics, offer direction on sharing information before and after the death of an individual research participant.
Genocea Biosciences Inc., a vaccine discovery and development company pioneering a new class of T cell-based vaccines, today announced that it has closed a $35 million Series B round of venture financing, with new investors Johnson & Johnson Development Corporation (JJDC), Skyline Ventures and MP Healthcare Venture Management, Inc. (MPH) joining existing investors Polaris Venture Partners, Lux Capital Management, SR One, Cycad Group, Auriga Partners and Morningside Ventures.
University of Miami researchers have discovered a clue in the humble zebrafish's digestive tract that, one day, could help people on the autism spectrum alleviate one of the most common yet least studied symptoms of their disorder: gastrointestinal distress.
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership leading the development of new and affordable tuberculosis (TB) drugs, announced today a new grant and pledge of up to $40 million over the next five years from the United States Agency for International Development (USAID).
› Verified 8 days ago
| Entity Name | Schuylkill Health System Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588603567 PECOS PAC ID: 0840285532 Enrollment ID: O20040420001197 |
News Archive
Researchers have identified a potential biological mechanism that could explain why oral contraceptives may be less effective at preventing pregnancy in obese women, as some epidemiological studies have indicated.
A blue-ribbon project group funded by the National Institutes of Health has published the first consensus guidelines on how researchers should share genomic findings in research on adults and children with other family members. The recommendations, published in the Journal of Law, Medicine & Ethics, offer direction on sharing information before and after the death of an individual research participant.
Genocea Biosciences Inc., a vaccine discovery and development company pioneering a new class of T cell-based vaccines, today announced that it has closed a $35 million Series B round of venture financing, with new investors Johnson & Johnson Development Corporation (JJDC), Skyline Ventures and MP Healthcare Venture Management, Inc. (MPH) joining existing investors Polaris Venture Partners, Lux Capital Management, SR One, Cycad Group, Auriga Partners and Morningside Ventures.
University of Miami researchers have discovered a clue in the humble zebrafish's digestive tract that, one day, could help people on the autism spectrum alleviate one of the most common yet least studied symptoms of their disorder: gastrointestinal distress.
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership leading the development of new and affordable tuberculosis (TB) drugs, announced today a new grant and pledge of up to $40 million over the next five years from the United States Agency for International Development (USAID).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Natasha Mozumdar Carlson, MD 1730 Chew St, Allentown, PA 18104-5549 Ph: (610) 969-3500 | Natasha Mozumdar Carlson, MD 3794 Hecktown Rd Ste 250, Easton, PA 18045-2355 Ph: (484) 546-5800 |
News Archive
Researchers have identified a potential biological mechanism that could explain why oral contraceptives may be less effective at preventing pregnancy in obese women, as some epidemiological studies have indicated.
A blue-ribbon project group funded by the National Institutes of Health has published the first consensus guidelines on how researchers should share genomic findings in research on adults and children with other family members. The recommendations, published in the Journal of Law, Medicine & Ethics, offer direction on sharing information before and after the death of an individual research participant.
Genocea Biosciences Inc., a vaccine discovery and development company pioneering a new class of T cell-based vaccines, today announced that it has closed a $35 million Series B round of venture financing, with new investors Johnson & Johnson Development Corporation (JJDC), Skyline Ventures and MP Healthcare Venture Management, Inc. (MPH) joining existing investors Polaris Venture Partners, Lux Capital Management, SR One, Cycad Group, Auriga Partners and Morningside Ventures.
University of Miami researchers have discovered a clue in the humble zebrafish's digestive tract that, one day, could help people on the autism spectrum alleviate one of the most common yet least studied symptoms of their disorder: gastrointestinal distress.
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership leading the development of new and affordable tuberculosis (TB) drugs, announced today a new grant and pledge of up to $40 million over the next five years from the United States Agency for International Development (USAID).
› Verified 8 days ago
Dr. Cheryle R Hart, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2651 Farmhouse Ct S, Easton, PA 18045 Phone: 716-435-4911 Fax: 610-438-0336 | |
Dr. Darshan B. Patel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2450 Butler St, Easton, PA 18042 Phone: 610-991-3136 | |
Michaela Ortiz, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1700 St Lukes Blvd, Easton, PA 18045 Phone: 484-526-1000 | |
Dr. Leonor Forero, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2925 William Penn Hwy, Suite 201, Easton, PA 18045 Phone: 610-258-1400 Fax: 610-258-3047 | |
John W Caruno, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 2461 Nazareth Rd, Easton, PA 18045 Phone: 610-268-5300 Fax: 610-258-5138 | |
Dr. Mark A Casaia, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2925 William Penn Hwy, Suite 201, Easton, PA 18045 Phone: 610-258-1400 Fax: 610-258-3047 | |
Vanessa Eiswerth, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 St Lukes Blvd Ste 200, Easton, PA 18045 Phone: 484-503-3020 |